Prions: Protein Aggregation and Infectious Diseases - Physiological ...

More documents

Recommendations

Info

1146 ADRIANO AGUZZI AND ANNA MARIA CALELLA tor-kappa B activity in the brains of scrapie-infected mice. Brain Res 73: 17–27, 1999. 257. Kimberlin RH, Hall SM, Walker CA. Pathogenesis of mouse scrapie. Evidence for direct neural spread of infection to the CNS after injection of sciatic nerve. J Neurol Sci 61: 315–325, 1983. 258. Kimberlin RH, Walker CA. Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose-response curves. J Comp Pathol 88: 39–47, 1978. 259. Kimberlin RH, Walker CA. Pathogenesis of scrapie in mice after intragastric infection. Virus Res 12: 213–220, 1989. 260. Kirschbaum WR. Zwei eigenartige Erkrankungen des Zentralnervensystems nach Art der spastischen Pseudosklerose (Jakob). Z Ges Neurol Psychiatr 92: 175–220, 1924. 261. Kisilevsky R. Preparation and propagation of amyloid-enhancing factor. Methods Mol Biol 299: 237–241, 2005. 262. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605–608, 1998. 263. Kitamoto T, Muramoto T, Mohri S, Doh ura K, Tateishi J. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J Virol 65: 6292–6295, 1991. 264. Kitamoto T, Tateishi J. Human prion diseases with variant prion protein. Philos Trans R Soc Lond B Biol Sci 343: 391–398, 1994. 265. Kitamoto T, Tateishi J, Tashima T, Takeshita I, Barry RA, DeArmond SJ, Prusiner SB. Amyloid plaques in Creutzfeldt- Jakob disease stain with prion protein antibodies. Ann Neurol 20: 204–208, 1986. 266. Kitamura D, Roes J, Kuhn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350: 423–426, 1991. 267. Klein MA, Frigg R, Flechsig E, Raeber AJ, Kalinke U, Bluethmann H, Bootz F, Suter M, Zinkernagel RM, Aguzzi A. A crucial role for B cells in neuroinvasive scrapie. Nature 390: 687– 690, 1997. 268. Klein MA, Frigg R, Raeber AJ, Flechsig E, Hegyi I, Zinkernagel RM, Weissmann C, Aguzzi A. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat Med 4: 1429– 1433, 1998. 269. Klein MA, Kaeser PS, Schwarz P, Weyd H, Xenarios I, Zinkernagel RM, Carroll MC, Verbeek JS, Botto M, Walport MJ, Molina H, Kalinke U, Acha-Orbea H, Aguzzi A. Complement facilitates early prion pathogenesis. Nat Med 7: 488–492, 2001. 270. Klohn PC, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci USA 100: 11666–11671, 2003. 271. Knaus KJ, Morillas M, Swietnicki W, Malone M, Surewicz WK, Yee VC. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 8: 770–774, 2001. 272. Knowles T, Fitzpatrick A, Meehan S, Mott H, Vendruscolo M, Dobson C, Welland M. Role of intermolecular forces in defining material properties of protein nanofibrils. Science 318: 1900–1903, 2007. 273. Kocisko DA, Vaillant A, Lee KS, Arnold KM, Bertholet N, Race RE, Olsen EA, Juteau JM, Caughey B. Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides. Antimicrob Agents Chemother 50: 1034–1044, 2006. 274. Koller MF, Grau T, Christen P. Induction of antibodies against murine full-length prion protein in wild-type mice. J Neuroimmunol 132: 113–116, 2002. 275. Kong Q, Huang S, Zou W, Vanegas D, Wang M, Wu D, Yuan J, Zheng M, Bai H, Deng H, Chen K, Jenny AL, O’Rourke K, Belay ED, Schonberger LB, Petersen RB, Sy MS, Chen SG, Gambetti P. Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci 25: 7944–7949, 2005. 276. Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 6: 491–500, 1997. 277. Kooyman DL, Byrne GW, Logan JS. Glycosyl phosphatidylinositol anchor. Exp Nephrol 6: 148–151, 1998. Physiol Rev VOL 89 OCTOBER 2009 www.prv.org 278. Kooyman DL, Byrne GW, McClellan S, Nielsen D, Tone M, Waldmann H, Coffman TM, McCurry KR, Platt JL, Logan JS. In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 269: 89–92, 1995. 279. Korth C, Stierli B, Streit P, Moser M, Schaller O, Fischer R, Schulz-Schaeffer W, Kretzschmar H, Raeber A, Braun U, Ehrensperger F, Hornemann S, Glockshuber R, Riek R, Billeter M, Wuthrich K, Oesch B. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 390: 74–77, 1997. 280. Kovacs GG, Head MW, Bunn T, Laszlo L, Will RG, Ironside JW. Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 26: 463–472, 2000. 281. Kovacs GG, Lindeck-Pozza E, Chimelli L, Araujo AQ, Gabbai AA, Strobel T, Glatzel M, Aguzzi A, Budka H. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle. Ann Neurol 55: 121–125, 2004. 282. Kranich J, Krautler NJ, Heinen E, Polymenidou M, Bridel C, Schildknecht A, Huber C, Kosco-Vilbois MH, Zinkernagel R, Miele G, Aguzzi A. Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8. J Exp Med 205: 1293–1302, 2008. 283. Kratz A, Campos-Neto A, Hanson MS, Ruddle NH. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 183: 1461–1472, 1996. 284. Kristiansen M, Deriziotis P, Dimcheff DE, Jackson GS, Ovaa H, Naumann H, Clarke AR, van Leeuwen FW, Menendez- Benito V, Dantuma NP, Portis JL, Collinge J, Tabrizi SJ. Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell 26: 175–188, 2007. 285. Kristiansen M, Messenger MJ, Klohn PC, Brandner S, Wadsworth JD, Collinge J, Tabrizi SJ. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase-activation and apoptosis. J Biol Chem 280: 38851–38861, 2005. 286. Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Matsumoto Y, Yokoyama T, Itohara S, Onodera T. Prions prevent neuronal cell-line death. Nature 400: 225–226, 1999. 287. Lacroux C, Simon S, Benestad SL, Maillet S, Mathey J, Lugan S, Corbiere F, Cassard H, Costes P, Bergonier D, Weisbecker JL, Moldal T, Simmons H, Lantier F, Feraudet-Tarisse C, Morel N, Schelcher F, Grassi J, Andreoletti O. Prions in milk from ewes incubating natural scrapie. PLoS Pathog 4: e1000238, 2008. 288. Lansbury PT. Mechanism of scrapie replication. Science 265: 1510, 1994. 289. Laplanche JL, Chatelain J, Launay JM, Gazengel C, Vidaud M. Deletion in prion protein gene in a Moroccan family. Nucleic Acids Res 18: 6745, 1990. 290. Larson J, Lynch G, Games D, Seubert P. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res 840: 23–35, 1999. 291. Lasmezas CI, Cesbron JY, Deslys JP, Demaimay R, Adjou KT, Rioux R, Lemaire C, Locht C, Dormont D. Immune systemdependent and -independent replication of the scrapie agent. J Virol 70: 1292–1295, 1996. 292. Lau AL, Yam AY, Michelitsch MM, Wang X, Gao C, Goodson RJ, Shimizu R, Timoteo G, Hall J, Medina-Selby A, Coit D, McCoin C, Phelps B, Wu P, Hu C, Chien D, Peretz D. Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC. Proc Natl Acad Sci USA 104: 11551– 11556, 2007. 293. Le Pichon CE, Valley MT, Polymenidou M, Chesler AT, Sagdullaev BT, Aguzzi A, Firestein S. Olfactory behavior and physiology are disrupted in prion protein knockout mice. Nat Neurosci 12: 60–69, 2009. 294. Leblanc P, Alais S, Porto-Carreiro I, Lehmann S, Grassi J, Raposo G, Darlix JL. Retrovirus infection strongly enhances scrapie infectivity release in cell culture. EMBO J 25: 2674–2685, 2006. 295. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB. Synthetic mammalian prions. Science 305: 673–676, 2004.
296. Legname G, Nguyen HO, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA 103: 19105–19110, 2006. 297. Li A, Christensen H, Stewart L, Roth K, Chiesa R, Harris D. Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105–125. EMBO J 26: 548–558, 2007. 298. Li A, Sakaguchi S, Shigematsu K, Atarashi R, Roy BC, Nakaoke R, Arima K, Okimura N, Kopacek J, Katamine S. Physiological expression of the gene for PrP-like protein, PrPLP/Dpl, by brain endothelial cells and its ectopic expression in neurons of PrP-deficient mice ataxic due to Purkinje cell degeneration. Am J Pathol 157: 1447–1452, 2000. 299. Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Bjorklund A, Widner H, Revesz T, Lindvall O, Brundin P. Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation. Nat Med 14: 501–503, 2008. 300. Ligios C, Sigurdson CJ, Santucciu C, Carcassola G, Manco G, Basagni M, Maestrale C, Cancedda MG, Madau L, Aguzzi A. PrPSc in mammary glands of sheep affected by scrapie and mastitis. Nat Med 11: 1137–1138, 2005. 301. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 88: 673–728, 2008. 302. Liu T, Li R, Pan T, Liu D, Petersen RB, Wong BS, Gambetti P, Sy MS. Intercellular transfer of the cellular prion protein. J Biol Chem 277: 47671–47678, 2002. 303. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363: 417– 421, 2004. 304. Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P. alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson’s disease. Proc Natl Acad Sci USA 99: 10813–10818, 2002. 305. Locht C, Chesebro B, Race R, Keith JM. Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent. Proc Natl Acad Sci USA 83: 6372– 6376, 1986. 306. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487– 501, 2001. 307. Lu K, Wang W, Xie Z, Wong BS, Li R, Petersen RB, Sy MS, Chen SG. Expression and structural characterization of the recombinant human doppel protein. Biochemistry 39: 13575–13583, 2000. 308. Lundmark K, Westermark GT, Nystrom S, Murphy CL, Solomon A, Westermark P. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci USA 99: 6979– 6984, 2002. 309. Lysek DA, Schorn C, Nivon LG, Esteve-Moya V, Christen B, Calzolai L, von Schroetter C, Fiorito F, Herrmann T, Güntert P, Wüthrich K. Prion protein NMR structures of cats, dogs, pigs, and sheep. Proc Natl Acad Sci USA 102: 640–645, 2005. 310. M’Fadyean JM. Scrapie. J Comp Pathol 31: 102–131, 1918. 311. M’Gowan JP. Investigation into the Disease of Sheep Called “Scrapie.” Edinburgh: William Blackwood, 1914. 312. Ma J, Lindquist S. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 298: 1785–1788, 2002. 313. Ma J, Lindquist S. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci USA 98: 14955–14960, 2001. 314. Ma J, Wollmann R, Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298: 1781– 1785, 2002. 315. Mabbott NA, Bruce ME, Botto M, Walport MJ, Pepys MB. Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat Med 7: 485–487, 2001. 316. Mabbott NA, Mackay F, Minns F, Bruce ME. Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nat Med 6: 719–720, 2000. AGGREGATION AND INFECTIOUS DISEASE 1147 Physiol Rev VOL 89 OCTOBER 2009 www.prv.org 317. Mabbott NA, MacPherson GG. Prions and their lethal journey to the brain. Nat Rev Microbiol 4: 201–211, 2006. 318. Mackay F, Majeau GR, Lawton P, Hochman PS, Browning JL. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur J Immunol 27: 2033–2042, 1997. 319. Mahal SP, Baker CA, Demczyk CA, Smith EW, Julius C, Weissmann C. Prion strain discrimination in cell culture: the cell panel assay. Proc Natl Acad Sci USA 104: 20908–20913, 2007. 320. Malisauskas M, Ostman J, Darinskas A, Zamotin V, Liutkevicius E, Lundgren E, Morozova-Roche LA. Does the cytotoxic effect of transient amyloid oligomers from common equine lysozyme in vitro imply innate amyloid toxicity? J Biol Chem 280: 6269–6275, 2005. 321. Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302: 871–874, 2003. 322. Mallucci GR, Ratte S, Asante EA, Linehan J, Gowland I, Jefferys JG, Collinge J. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 21: 202–210, 2002. 323. Mallucci GRWM, Farmer M, Dickinson A, Khatun H, Powell AD, Brandner S, Jefferys JG, Collinge J. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 53: 325–335, 2007. 324. Malmgren R, Kurland L, Mokri B, Kurtzke J. The epidemiology of Creutzfeldt-Jakob disease. In: Slow Transmissible Diseases of the Nervous System, edited by Prusiner SB, Hadlow WJ. New York: Academic, 1979, p. 93–112. 325. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8: 121–127, 1994. 326. Manson JC, Clarke AR, McBride PA, McConnell I, Hope J. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3: 331–340, 1994. 327. Manuelidis EE, de Figueiredo JM, Kim JH, Fritch WW, Manuelidis L. Transmission studies from blood of Alzheimer disease patients and healthy relatives. Proc Natl Acad Sci USA 85: 4898– 4901, 1988. 328. Marsh RF, Hadlow WJ. Transmissible mink encephalopathy. Rev Sci Tech 11: 539–550, 1992. 329. Marsh RF, Kimberlin RH. Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology, and pathogenesis. J Infect Dis 131: 104–110, 1975. 330. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287: 1265–1269, 2000. 331. Masters CL, Richardson EP. Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 101: 333–344, 1978. 332. Mathiason CK, Powers JG, Dahmes SJ, Osborn DA, Miller KV, Warren RJ, Mason GL, Hays SA, Hayes-Klug J, Seelig DM, Wild MA, Wolfe LL, Spraker TR, Miller MW, Sigurdson CJ, Telling GC, Hoover EA. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 314: 133–136, 2006. 333. Matsumoto M, Fu YX, Molina H, Huang G, Kim J, Thomas DA, Nahm MH, Chaplin DD. Distinct roles of lymphotoxin alpha and the type I tumor necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from non-bone marrow-derived cells. J Exp Med 186: 1997–2004, 1997. 334. Mawhinney S, Pape WJ, Forster JE, Anderson CA, Bosque P, Miller MW. Human prion disease and relative risk associated with chronic wasting disease. Emerg Infect Dis 12: 1527–1535, 2006. 335. McBride PA, Beekes M. Pathological PrP is abundant in sympathetic and sensory ganglia of hamsters fed with scrapie. Neurosci Lett 265: 135–138, 1999. 336. McBride PA, Schulz-Schaeffer WJ, Donaldson M, Bruce M, Diringer H, Kretzschmar HA, Beekes M. Early spread of scrapie from the gastrointestinal tract to the central nervous system in-
Page 1 and 2: Prions: Protein Aggregation and Inf
Page 3 and 4: suggesting that CJD was also a gene
Page 5 and 6: egion in mouse chromosome 2 (479).
Page 7 and 8: merized into rod-shaped particles w
Page 9 and 10: hosts, exhibit distinct prion-disea
Page 11 and 12: eported that polyglutamine aggregat
Page 13 and 14: ogy, and perhaps even to devising t
Page 15 and 16: parietal cortex, of all animals (64
Page 17 and 18: appears to be a direct relationship
Page 19 and 20: cases in Colorado and Wyoming, wher
Page 21 and 22: all fCJD, the clinicopathological d
Page 23 and 24: were still present in 7 / mice. In
Page 25 and 26: generation and maintenance of FDCs
Page 27 and 28: including the kidney. In fact, in v
Page 29 and 30: spleens of sCJD patients (183) indi
Page 31 and 32: Congo red (98), amphotericin B, ant
Page 33 and 34: despite these promising results, Cp
Page 35 and 36: enate diluted in plasma, thereby yi
Page 37 and 38: 36. Banks WA, Niehoff ML, Adessi C,
Page 39 and 40: Jakob disease in England and Wales
Page 41: 213. Heppner FL, Greter M, Marino D
Page 45 and 46: 371. Ohhashi Y, Kihara M, Naiki H,
Page 47 and 48: 453. Shmerling D, Hegyi I, Fischer

Prions: Protein Aggregation and Infectious Diseases - Physiological ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?